Analysts Set Expectations for Iovance Biotherapeutics, Inc.'s FY2023 Earnings (NASDAQ:IOVA)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) – Research analysts at HC Wainwright lifted their FY2023 EPS estimates for shares of Iovance Biotherapeutics in a research note issued on Wednesday, November 8th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will post earnings of ($1.90) per share for the year, up from […]